Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 12;9(8):e104527.
doi: 10.1371/journal.pone.0104527. eCollection 2014.

Periodontal regeneration using strontium-loaded mesoporous bioactive glass scaffolds in osteoporotic rats

Affiliations

Periodontal regeneration using strontium-loaded mesoporous bioactive glass scaffolds in osteoporotic rats

Yufeng Zhang et al. PLoS One. .

Abstract

Recent studies demonstrate that the rate of periodontal breakdown significantly increased in patients compromised from both periodontal disease and osteoporosis. One pharmacological agent used for their treatment is strontium renalate due to its simultaneous ability to increase bone formation and halt bone resorption. The aim of the present study was to achieve periodontal regeneration of strontium-incorporated mesoporous bioactive glass (Sr-MBG) scaffolds in an osteoporotic animal model carried out by bilateral ovariectomy (OVX). 15 female Wistar rats were randomly assigned to three groups: control unfilled periodontal defects, 2) MBG alone and 3) Sr-MBG scaffolds. 10 weeks after OVX, bilateral fenestration defects were created at the buccal aspect of the first mandibular molar and assessed by micro-CT and histomorphometric analysis after 28 days. Periodontal fenestration defects treated with Sr-MBG scaffolds showed greater new bone formation (46.67%) when compared to MBG scaffolds (39.33%) and control unfilled samples (17.50%). The number of TRAP-positive osteoclasts was also significantly reduced in defects receiving Sr-MBG scaffolds. The results from the present study suggest that Sr-MBG scaffolds may provide greater periondontal regeneration. Clinical studies are required to fully characterize the possible beneficial effect of Sr-releasing scaffolds for patients suffering from a combination of both periodontal disease and osteoporosis.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Establishment of rat osteoporotic model created by OVX.
3D µ-CT images of normal bone and osteoporotic bone as well as their representative H&E staining.
Figure 2
Figure 2. The overall state of bone regeneration was exhibited by 3D reconstruction.
The red box represented the original extent of surgical defect in general. A, D and G: buccal view; B, E and H: screenshot in horizontal; C, F and I: screenshot in vertical. Bar: 1 mm.
Figure 3
Figure 3. Statistical analysis of periodontal regeneration: A) proportion of mineralized tissue from horizontal cutaway view of 3D construction, B) area of new bone from H&E stain, C) defect fill from Masson trichrome stain and D) the number of TRAP-positive cells from TRAP stain.
Results were given by mean ±SD. *: p<0.05, **: p<0.01.
Figure 4
Figure 4. Representative sections of H&E stain (A, C and E) revealed the osteogenesis among the defects.
New bone was visible in the area adjacent to the old bone and implanted scaffolds. Representative sections of Masson trichrome stain (B, D and F) revealed the compound of collagen in the osteogenic active zone. Bar: 200 µm. R: Root, F =  Fibroblasts, NB =  New bone, OB =  Old bone, M =  Material.
Figure 5
Figure 5. TRAP-staining for A) control, B) MBG alone and C) Sr-MBG scaffolds.
Positive cells were visible in the surface of bone (control, MBG and Sr-MBG) and scaffolds (MBG and Sr-MBG). Bar: 100 µm. Arrows depict areas of TRAP-staining, NB =  New bone, M =  Material.

Similar articles

Cited by

References

    1. Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, et al. (1999) Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 10: 259–264. - PubMed
    1. Tontonoz P, Pei LM (2004) Fat's loss is bone's gain. Journal of Clinical Investigation 113: 805–806. - PMC - PubMed
    1. Rodan GA, Martin TJ (2000) Therapeutic approaches to bone diseases. Science 289: 1508–1514. - PubMed
    1. Silva BC, Bilezikian JP (2011) New approaches to the treatment of osteoporosis. Annu Rev Med 62: 307–322. - PubMed
    1. Boonen S, Ferrari S, Miller PD, Eriksen EF, Sambrook PN, et al. (2012) Postmenopausal osteoporosis treatment with antiresorptives: effects of discontinuation or long-term continuation on bone turnover and fracture risk–a perspective. J Bone Miner Res 27: 963–974. - PubMed

Publication types